{"product_id":"ss-31-elamipretide-peptide-intelligence-monograph","title":"SS-31 (Elamipretide) — Peptide Intelligence Monograph","description":"\u003cp class=\"PDq2pG_selectionAnchorContainer\"\u003e\u003cstrong\u003eShort description\u003c\/strong\u003e\u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThe Evidence Behind the Hype.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA physician-reviewed, evidence-based examination of SS-31 (elamipretide) from the Founder’s Institute of Medicine \u0026amp; Education.\u003c\/p\u003e\n\u003cp\u003eThis digital monograph separates findings from human clinical studies from mechanistic and preclinical research, emerging therapeutic hypotheses, and claims that remain unproven.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFull product description\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSS-31 has attracted attention as a mitochondria-targeting peptide. But what does the evidence actually show?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSS-31, also known as elamipretide, is a mitochondria-targeting peptide studied for its interactions with the inner mitochondrial membrane and cardiolipin, with potential downstream effects on mitochondrial structure, energetics, and cellular function.\u003c\/p\u003e\n\u003cp\u003eIts biological rationale is compelling—but mechanistic plausibility is not the same as demonstrated clinical benefit.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003eSS-31 (Elamipretide) Peptide Intelligence Monograph\u003c\/strong\u003e examines the evidence systematically, distinguishing laboratory findings and biological mechanisms from observations in human studies and conclusions that can actually be supported clinically.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eInside the monograph:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSS-31 structure, pharmacology, and mitochondrial targeting\u003c\/li\u003e\n\u003cli\u003eCardiolipin and inner mitochondrial membrane biology\u003c\/li\u003e\n\u003cli\u003eProposed effects on mitochondrial energetics and oxidative stress\u003c\/li\u003e\n\u003cli\u003ePreclinical evidence across organ systems\u003c\/li\u003e\n\u003cli\u003eHuman clinical-trial evidence\u003c\/li\u003e\n\u003cli\u003eInvestigational disease-specific applications\u003c\/li\u003e\n\u003cli\u003eSafety and tolerability findings\u003c\/li\u003e\n\u003cli\u003eRegulatory and investigational status\u003c\/li\u003e\n\u003cli\u003eLimitations, uncertainties, and important evidence gaps\u003c\/li\u003e\n\u003cli\u003eClaim-by-claim \u003cstrong\u003eFIPES evidence grading\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eWhat we know, what we do not know, and what research is still needed\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePhysician reviewed. Evidence graded. No protocols. No dosing instructions. No promotional claims.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis publication is intended for education and scientific evidence review. It is not medical advice and does not recommend or instruct the use of SS-31 (elamipretide).\u003c\/p\u003e","brand":"Founder's Institute of Medicine \u0026 Education","offers":[{"title":"Default Title","offer_id":45379706847414,"sku":null,"price":24.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0736\/0990\/4310\/files\/ChatGPTImageAug26_2026_09_24_49PM.png?v=1787808355","url":"https:\/\/foundersinstitutemed.org\/products\/ss-31-elamipretide-peptide-intelligence-monograph","provider":"Founder's Institute of Medicine \u0026 Education","version":"1.0","type":"link"}